Skip to main content
. 2001 Oct 23;2001(4):CD003159. doi: 10.1002/14651858.CD003159

Saletu 1995.

Methods single centre, double blind, randomized, placebo controlled, parallel groups
Participants MID mild to moderate; 24 patients received nicergoline, 26 placebo; age > 60 yr.
Interventions Nicergoline or Placebo 30mg. twice a day (os) for 8 weeks
Outcomes SCAG, MMSE, CGI, EEG/ERP for efficacy; side effects for safety
Notes